Clinical Trials

Anatomic Stage II Breast Cancer AJCC v8

NCT04275661 2026-02-04

Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery

Phase 2 Completed

60 enrolled

Agnosia, Breast Neoplasms

NCT04799535 2026-02-03

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Recruiting

550 enrolled

Breast Neoplasms

NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

78 enrolled

Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

NCT06440850 2026-02-02

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

21 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT02897427 2026-01-26

TRINITY

Active not recruiting

1,500 enrolled

Papillomavirus Infections

NCT05989828 2026-01-14

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Phase 1 Suspended

20 enrolled

Triple Negative Breast Neoplasms

NCT05408260 2026-01-05

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

12 enrolled

Breast Neoplasms

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

120 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00987428 2025-11-20

EEPAB2

Phase NA Terminated

27 enrolled

Lymphoid

Lymphoma, Follicular

NCT04329065 2025-11-06

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

25 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT07016399 2025-10-30

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

51 enrolled

Triple Negative Breast Neoplasms

NCT00210223 2025-10-01

RF-SEIN

21 enrolled 6 charts

Breast Neoplasms

NCT00874458 2025-09-30

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

40 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04537871 2025-09-25

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Active not recruiting

350 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03672331 2025-09-18

MyPeBS

Phase NA Active not recruiting

53,142 enrolled

Breast Screening

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Phase 3 Active not recruiting

30 enrolled

Carcinoma, Lobular

NCT05336786 2025-09-04

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

70 enrolled

Genitourinary

Prostatic Neoplasms

NCT07120529 2025-08-13

MOOSE

Recruiting

300 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase NA Active not recruiting

798 enrolled

Phase 3 Enrolling by invitation

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07016737 2025-06-12

ESO-Nanjing12

79 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07005089 2025-06-05

Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts

Phase EARLY_PHASE1 Completed

48 enrolled

Gynecologic

Complex Ovarian Cyst

NCT04185337 2025-02-27

Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

23 enrolled

Tumor-Agnostic

Neoplasms

NCT06324721 2025-01-29

LymphSens

Phase NA Recruiting

230 enrolled

Breast Neoplasms, Lymphedema

NCT03982082 2025-01-15

Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients